title: Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene.
abstract: In type 2 diabetes, the threonine (Thr) for alanine (Ala) codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with elevated fasting and postprandial triglycerides and dyslipidemia when compared with the wild type (Ala-54/Ala-54). To assess whether this is the case in patients with type 1 diabetes, who usually do not manifest the metabolic syndrome, we screened 181 patients with similar glycemic control as the type 2 patients. Thirty percent were heterozygous, and 9% were homozygous for the polymorphism. Mean (+/-SEM) fasting plasma triglyceride levels in patients with the wild type (n = 84), those heterozygous for Ala-54/Thr-54 (n = 44), and those homozygous for the Thr-54 (n = 13) were 1.0 +/- 0.07, 1.1 +/- 0.17, and 1.2 +/- 0.23 mmol/liter, respectively. In addition, there were no differences in total, low-density lipoprotein, high-density lipoprotein, and non-high density lipoprotein cholesterol among the three groups. After a fat load, the postprandial area under the curve of triglyceride in plasma, chylomicrons, and very low-density lipoprotein were similar between the wild type (n = 18) and the Thr-54 homozygotes (n = 12). In conclusion, in contrast to type 2, type 1 diabetes does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene to cause hypertriglyceridemia/dyslipidemia. Insulin resistance could account possibly for this difference.
authors.affiliation: Minneapolis Veterans Affairs Medical Center, Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55417, USA. georg003@tc.umn.edu
authors.forename: Angeliki
authors.initials: A
authors.lastname: Georgopoulos
authors.forename: Omer
authors.initials: O
authors.lastname: Aras
authors.forename: Marina
authors.initials: M
authors.lastname: Noutsou
authors.forename: Michael Y
authors.initials: MY
authors.lastname: Tsai
mesh_terms: D000328:Adult; D001786:Blood Glucose; D002352:Carrier Proteins / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D004041:Dietary Fats; D005215:Fasting; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D006720:Homozygote; D006801:Humans; D015228:Hypertriglyceridemia / Q000175:diagnosis / Q000235:genetics; D008875:Middle Aged; D009363:Neoplasm Proteins; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D019518:Postprandial Period; D025521:Tumor Suppressor Proteins
chemical_list: D001786:Blood Glucose; D002352:Carrier Proteins; D004041:Dietary Fats; C107608:FABP7 protein, human; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D009363:Neoplasm Proteins; D025521:Tumor Suppressor Proteins